Management Change/Compensation - Form 8-K

On March 25, 2024, based on a recent analysis of similarly situated companies, feedback from our stockholders, and other considerations, the Board of Directors (the "Board") of Neuronetics, Inc. (the "Company") determined that it would reduce the number of directors serving on the Board from eight to five effective immediately after the Company's 2024 annual meeting of stockholders (the "2024 Annual Meeting"). Following this determination, Messrs. John K. Bakewell and Joseph H. Capper and Dr. Wilfred E. Jaeger advised the Company that they would not stand for reelection to the Board at the 2024 Annual Meeting. The decision not to seek election to the Board did not result from any disagreements with the Company regarding any matter related to the Company's operations, policies, or practices. Their service on the Board and the Board's committees will end at the conclusion of the 2024 Annual Meeting.